In addition, previous studies also suggested SGK1 was important for breast cancer growth and resistance to PI3K inhibitors [27, 28], indicating that targeting SGK1 would generate pleiotropic antitumor effects. The gene discussed is PIK3CA; the disease is breast carcinoma.